Delivery Order SPE2DB22D2211-SPE2DB25FSDUX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp on July 29, 2025, for supply of XDEMVY 0.25% Drop 10ML pharmaceutical product. This is an unset-aside, competitively awarded firm fixed price delivery order with an ultimate completion date of August 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for XDEMVY 0.25% drop in 10ml format, valued at $1,223.59 with a firm fixed price structure. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order is non-competitive...
- The Defense Logistics Agency awarded a $2,447.18 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml format, with a firm fixed price structure and an ultimate completion date of September 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value and runs through December...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for XDEMVY 0.25% Drop in 10ml format, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ML format, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a $4,894.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. The...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDUXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for XDEMVY 0.25% drop in 10 mL format, with a ceiling value of $1,223.59. This firm fixed-price delivery order, which is not set-aside, is set to conclude on September 18, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. As the prime vendor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems, the Defense Health Agency, and other government entities worldwide. This specific delivery order for the ophthalmic medication represents one of numerous small-to-mid-value transactions executed under the broader pharmaceutical prime vendor agreement designed to ensure responsive supply chain support for defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/27/25 |